Study of CAD-9303 in Subjects With Schizophrenia
Clinical trial NCT04306146 · COMPLETED
Trial details
- NCT number
- NCT04306146
- Sponsor
- Cadent Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-28
- Primary completion
- 2021-09-22
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.